ADAMTS12
ADAMTS12 is a member of the ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin Motifs) family of proteins. These proteins are known for their roles in the processing of extracellular matrix components, and they have been implicated in various biological processes and diseases.
Structure[edit]
ADAMTS12 is a large, multi-domain protein that includes a signal peptide, a propeptide, a metalloproteinase domain, a disintegrin-like domain, a thrombospondin type 1 motif, and several other domains that contribute to its function. The structure of ADAMTS12 allows it to interact with various substrates and other proteins in the extracellular matrix.
Function[edit]
The primary function of ADAMTS12 is to modulate the extracellular matrix by cleaving specific substrates. It is involved in the degradation of proteoglycans, which are important components of the extracellular matrix. This activity is crucial for tissue remodeling, cell migration, and other processes.
ADAMTS12 has been shown to play a role in angiogenesis, the formation of new blood vessels, and is involved in the regulation of inflammation. It is also implicated in the pathogenesis of certain diseases, including osteoarthritis and cancer.
Clinical Significance[edit]
Alterations in the expression or activity of ADAMTS12 have been associated with various diseases. For example, increased expression of ADAMTS12 has been observed in certain types of cancer, suggesting a role in tumor progression and metastasis. Conversely, mutations or deficiencies in ADAMTS12 may contribute to the development of osteoarthritis by affecting cartilage integrity.
Research is ongoing to better understand the precise roles of ADAMTS12 in health and disease, and to explore its potential as a therapeutic target.
Also see[edit]
| Proteases: metalloendopeptidases (EC 3.4.24) | ||||||
|---|---|---|---|---|---|---|
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian